Dear all members of Imexpharm,
As 2023 unfolds, it continues to capture the stories of individuals and organizations alike. For Imexpharm, this year marks 46 years of establishment and growth, a significant milestone in its journey.
Throughout its long journey filled with hardships and challenges, the company has remained steadfast in its unity and relentless in its efforts. The dedication of all employees, along with the support of partners, shareholders, and collaborators, has empowered Imexpharm to overcome challenges and set new records along the way. As Imexpharm celebrates its 46th year in 2023, it is a fitting moment to reflect on the past, proud of the milestones achieved and progress aligned with its goals, while embracing the promise of a new era.
Looking back to 1977, the establishment of Imexpharm’s predecessor, the Second-Class Pharmaceutical Company, laid a solid foundation for the brand’s success in both domestic and international markets as we see today. One of the most significant events in Imexpharm’s history was the devastating factory fire in 1994, which forced the company to start from scratch. In the midst of economic and social reform, this was a severe setback for such a young company. However, the unity and dedication of its employees, along with support from partners and peer companies, enabled Imexpharm to overcome the challenge and continue its growth.
Since then, Imexpharm has made remarkable strides, cementing a strong position in the pharmaceutical industry. Over the years, through ups and downs, we are so proud that Imexpharm has consistently been willing to explore new fields, push boundaries and set new precedents. In 1997, it became the first Vietnamese pharmaceutical company to earn GMP-ASEAN certification. It led the way in 2001 by becoming the first to undergo equitization and, in 2006, the first to be publicly listed on the stock exchange. Imexpharm continued to lead in 2013 as the first pharmaceutical company in Vietnam to implement the SAP-ERP management system, boosting operational efficiency. In 2016, Imexpharm became the first in Vietnam to own three EU-GMP certified production lines, evaluated by Spain's Ministry of Health, underscoring its commitment to global standards. More recently, in 2021, Imexpharm inaugurated a Health Protection Food factory at its headquarters in Cao Lanh City, marking a significant investment of nearly 90 billion VND into expanding product offerings to enhance public health.
Achieving these milestones has been a journey spanning 46 years, during which Imexpharm has consistently embraced opportunities to invest in cutting-edge technology and state-of-the-art infrastructure. Through the construction of world-standard factories, prioritizing human resource development, expanding its product range, and harnessing technological innovation to sharpen its competitive edge, Imexpharm has fulfilled its commitments to investors, partners, employees, and the community. Today, the green lotus emblem stands as a testament to Imexpharm’s legacy on both the domestic and international pharmaceutical map.
In our interconnected world, Imexpharm proudly introduces itself across languages and cultures while honoring its roots in Dong Thap Muoi, a region that rose from the hardships of the post-war era. This pride echoes through generations of Imexpharm's employees, each committed to the company’s growth and inspired by the shared goal of continuous progress and enduring impact.
In 2023, Imexpharm is strategically positioned to strengthen its presence in the international market. By advancing its 2030 strategic roadmap, restructuring its management systems, and operationalizing the IMP4 factory, Imexpharm is expanding its export activities and attracting interest from countries worldwide. These initiatives underscore Imexpharm’s role in public health, raising awareness around life expectancy and healthcare quality.
Imexpharm’s focus now extends beyond curing illness or generating revenue; it is dedicated to fostering a healthy workplace and encouraging both individuals and enterprises to prioritize their physical and mental well-being. This ensures that individual and corporate customers alike understand the value of Imexpharm’s products, ultimately benefiting communities wherever Imexpharm operates. This approach represents a “value revolution,” and Imexpharm is proud of its commitment to learning and continuous improvement over the past five years, resulting in the strong team and solid foundation it has today.
The year 2023 marks the beginning of a promising new term for Imexpharm’s 2023-2027 Board of Directors, highlighted by impressive results in the first six months: a 37% increase in revenue and a 59% growth in profit compared to the same period last year. Moreover, the deepened partnership with SK Group, a leading South Korean chaebol, positions Imexpharm to elevate its corporate management to new heights. SK Group’s involvement in Imexpharm’s governance brings world-class expertise and management experience, while also opening new pathways for growth and business expansion.
Support from SK Group enables Imexpharm to elevate corporate management quality, strengthen its competitive edge, and expand its business scale. By adopting advanced management methods and international standards, Imexpharm is optimizing operations, enhancing adaptability, and improving overall efficiency.
Imexpharm has come a long way to become a trusted and successful brand. With the dedication and passion of our employees, we have overcome countless challenges, and 2023 marks another significant turning point in our journey of growth. Imexpharm remains committed to continuous innovation, delivering high-quality products and services to our customers while fostering a happy, sustainable workplace for every team member.
With deep pride in our homeland, Imexpharm is dedicated to giving back through social and community initiatives. By partnering with organizations and individuals to promote public health, we constantly seek and apply new solutions to improve quality of life. Moreover, we are deeply invested in future generations and sustainable development, committed to nurturing local talent to meet evolving demands and ensuring that we pass down a strong legacy to our future teams.
For today and the many decades ahead, Imexpharm sincerely thanks all its employees who have accompanied and contributed wholeheartedly to the company's development. Your continuous efforts and investment have been vital to Imexpharm’s success today. We invite all members to join Imexpharm in exploring new possibilities, knowledge, and technology, and together, we will build a better future for everyone, including ourselves.
Imexpharm also wishes health and peace to all, as these are the most precious gifts we can hope for in modern life. We hope everyone finds the strength to face challenges both at work and in life. With the same heartfelt spirit as on our 45th anniversary, commemorating our “journey with the country through the years,” we express our deepest gratitude on behalf of past generations to each of you who have journeyed alongside Imexpharm—a path filled with challenges but also with true camaraderie. We are profoundly grateful for the opportunity life has given us to be together and to write this history.
Cao Lanh City, July 24, 2023
General Director
Trần Thị Đào